Inhibitory effects of hepatocyte growth factor and interleukin-6 on transforming growth factor-β1 mediated vocal fold fibroblast-myofibroblast differentiation

Annals of Otology, Rhinology and Laryngology

Volumn 119, Issue 5, 2010, Pages 350-357

  Vyas, Bimal ^a   Ishikawa, Keiko ^a   Duflo, Suzy ^a   Chen, Xia ^a   Thibeault, Susan L ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Fibroblast; Myofibroblast; Transforming growth factor 1; Vocal fold; Wound healing; smooth muscle actin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ALPHA SMOOTH MUSCLE ACTIN ANTIBODY; ANTIBODY; INTERLEUKIN 6; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SCATTER FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LARYNX INJURY; MYOFIBROBLAST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCAR FORMATION; VOCAL CORD; WESTERN BLOTTING;

EID: 77952305284     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348941011900513     Document Type: Article

References (27)

1. Benninger MS, Alessi D, Archer S, et al. Vocal fold scarring: current concepts and management. Otolaryngol Head Neck Surg 1996;115:474-482.
2. Alberts B, ed. Molecular biology of the cell. New York, NY: Garland, 1999.
3. Desmoulière A. Factors influencing myofibroblast differentiation during wound healing and fibrosis. Cell Biol Int 1995;19:471-476.
4. Desmoulière A, Gabbiani G. Myofibroblast differentiation during fibrosis. Exp Nephrol 1995;3:134-139.
5. Darby I, Skalli O, Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990;63:21-29.
6. Desmoulière A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995;146:56-66.
7. Torday JS, Torres E, Rehan VK. The role of fibroblast transdifferentiation in lung epithelial cell proliferation, differentiation, and repair in vitro. Pediatr Pathol Mol Med 2003;22:189-207.
8. Roy SG, Nozaki Y, Phan SH. Regulation of alpha-smooth muscle actin gene expression in myofibroblast differentiation from rat lung fibroblasts. Int J Biochem Cell Biol 2001;33:723-734.
9. Gamulescu MA, Chen Y, He S, et al. Transforming growth factor beta2-induced myofibroblastic differentiation of human retinal pigment epithelial cells: regulation by extracellular matrix proteins and hepatocyte growth factor. Exp Eye Res 2006;83:212-222.
10. Tiggelman AM, Linthorst C, Boers W, Brand HS, Chamuleau RA. Transforming growth factor-beta-induced collagen synthesis by human liver myofibroblasts is inhibited by alpha2- macroglobulin. J Hepatol 1997;26:1220-1228.
11. Thibeault SL, Li W, Bartley S. A method for identification of vocal fold lamina propria fibroblasts in culture. Otolaryngol Head Neck Surg 2008;139:816-822.
12. Duflo S, Thibeault SL, Li W, Shu XZ, Prestwich G. Effect of a synthetic extracellular matrix on vocal fold lamina propria gene expression in early wound healing. Tissue Eng 2006;12:3201-3207.
13. Thibeault SL, Bless DM, Gray SD. Interstitial protein alterations in rabbit vocal fold with scar. J Voice 2003;17:377-383.
14. Thibeault SL, Gray SD, Bless DM, Chan RW, Ford CN. Histologic and rheologic characterization of vocal fold scarring. J Voice 2002;16:96-104.
15. Thibeault SL, Rousseau B, Welham NV, Hirano S, Bless DM. Hyaluronan levels in acute vocal fold scar. Laryngoscope 2004;114:760-764. (Pubitemid 38548793)
16. Rousseau B, Hirano S, Chan RW, et al. Characterization of chronic vocal fold scarring in a rabbit model. J Voice 2004;18:116-124. (Pubitemid 38333018)
17. Rousseau B, Hirano S, Scheidt TD, et al. Characterization of vocal fold scarring in a canine model. Laryngoscope 2003;113:620-627.
18. Lim X, Tateya I, Tateya T, Muñoz-Del-Río A, Bless DM. Immediate inflammatory response and scar formation in wounded vocal folds. Ann Otol Rhinol Laryngol 2006;115:921-929.
19. Ohno T, Hirano S, Rousseau B. Gene expression of transforming growth factor-beta1 and hepatocyte growth factor during wound healing of injured rat vocal fold. Laryngoscope 2009;119:806-810.
20. Branski RC, Barbieri SS, Weksler BB, et al. Effects of transforming growth factor-beta1 on human vocal fold fibroblasts. Ann Otol Rhinol Laryngol 2009;118:218-226.
21. Vaughan MB, Howard EW, Tomasek JJ. Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res 2000;257:180-189.
22. Serini G, Gabbiana G. Modulation of alpha-smooth muscle actin expression in fibroblasts by transforming growth factor- beta isoforms: an in vivo and in vitro study. Wound Repair Regen 1996;4:278-287.
23. Hirano S, Bless D, Heisey D, Ford C. Roles of hepatocyte growth factor and transforming growth factor β1 in production of extracellular matrix by canine vocal fold fibroblasts. Laryngoscope 2003;113:144-148.
24. Ohno T, French LC, Hirano S, Ossoff RH, Rousseau B. Effect of hepatocyte growth factor on gene expression of extracellular matrix during wound healing of the injured rat vocal fold. Ann Otol Rhinol Laryngol 2008;117:696-702.
25. Gallucci RM, Lee EG, Tomasek JJ. IL-6 modulates alpha-smooth muscle actin expression in dermal fibroblasts from IL-6-deficient mice. J Invest Dermatol 2006;126:561-568.
26. Gallucci RM, Simeonova PP, Matheson JM, et al. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J 2000;14:2525-2531.
27. Liechty KW, Adzick NS, Crombleholme TM. Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair. Cytokine 2000;12:671-676.